Your browser doesn't support javascript.
loading
Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis.
Placek, Katerina; Benatar, Michael; Wuu, Joanne; Rampersaud, Evadnie; Hennessy, Laura; Van Deerlin, Vivianna M; Grossman, Murray; Irwin, David J; Elman, Lauren; McCluskey, Leo; Quinn, Colin; Granit, Volkan; Statland, Jeffrey M; Burns, Ted M; Ravits, John; Swenson, Andrea; Katz, Jon; Pioro, Erik P; Jackson, Carlayne; Caress, James; So, Yuen; Maiser, Samuel; Walk, David; Lee, Edward B; Trojanowski, John Q; Cook, Philip; Gee, James; Sha, Jin; Naj, Adam C; Rademakers, Rosa; Chen, Wenan; Wu, Gang; Paul Taylor, J; McMillan, Corey T.
Afiliação
  • Placek K; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Benatar M; Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Wuu J; Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Rampersaud E; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Hennessy L; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Van Deerlin VM; Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Grossman M; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Irwin DJ; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Elman L; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • McCluskey L; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Quinn C; Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Granit V; Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Statland JM; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Burns TM; Department of Neurology, University of Virginia Health System, Charlottesville, VA, USA.
  • Ravits J; Department of Neurosciences, University of California San Diego, San Diego, CA, USA.
  • Swenson A; Department of Neurology, University of Iowa, Iowa City, IA, USA.
  • Katz J; Forbes Norris ALS Center, California Pacific Medical Center, San Francisco, CA, USA.
  • Pioro EP; Department of Neurology, Cleveland Clinic, Cleveland, OH, USA.
  • Jackson C; Department of Neurology, University of Texas Health Science Center, San Antonio, TX, USA.
  • Caress J; Department of Neurology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • So Y; Department of Neurology, Stanford University Medical Center, San Jose, CA, USA.
  • Maiser S; Department of Neurology, University of Minnesota Medical Center, Minneapolis, MN, USA.
  • Walk D; Department of Neurology, University of Minnesota Medical Center, Minneapolis, MN, USA.
  • Lee EB; Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Trojanowski JQ; Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Cook P; Penn Image Computing Science Laboratory (PICSL), Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Gee J; Penn Image Computing Science Laboratory (PICSL), Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Sha J; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Naj AC; Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Rademakers R; Department of Pathology & Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Chen W; Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Wu G; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Paul Taylor J; Rare Diseases Clinical Research Network, National Institutes of Health, Bethesda, MD, USA.
  • McMillan CT; Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.
EMBO Mol Med ; 13(1): e12595, 2021 01 11.
Article em En | MEDLINE | ID: mdl-33270986
ABSTRACT
Amyotrophic lateral sclerosis (ALS) is a multi-system disease characterized primarily by progressive muscle weakness. Cognitive dysfunction is commonly observed in patients; however, factors influencing risk for cognitive dysfunction remain elusive. Using sparse canonical correlation analysis (sCCA), an unsupervised machine-learning technique, we observed that single nucleotide polymorphisms collectively associate with baseline cognitive performance in a large ALS patient cohort (N = 327) from the multicenter Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. We demonstrate that a polygenic risk score derived using sCCA relates to longitudinal cognitive decline in the same cohort and also to in vivo cortical thinning in the orbital frontal cortex, anterior cingulate cortex, lateral temporal cortex, premotor cortex, and hippocampus (N = 90) as well as post-mortem motor cortical neuronal loss (N = 87) in independent ALS cohorts from the University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Our findings suggest that common genetic polymorphisms may exert a polygenic contribution to the risk of cortical disease vulnerability and cognitive dysfunction in ALS.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Demência Frontotemporal / Disfunção Cognitiva / Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Demência Frontotemporal / Disfunção Cognitiva / Esclerose Lateral Amiotrófica Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article